Hot Companies To Watch In Right Now

Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its upcoming dividend payout. For more information, check out Everything Investors Need to Know About Ex-Dividend Dates

Below we highlight 10 big-name stocks going ex-dividend for the week of September 9-13, 2013:

1. Kohl’s

Kohl’s Corporation (KSS) is set to trade ex-dividend on Monday, September 9. The discount retailer offers a dividend yield of 2.72% based on Wednesday�� closing price of $51.45 and the company�� quarterly dividend payout of 35 cents per share. The stock is up 23.1% year-to-date. Dividend.com currently rates KSS as “Neutral” with a DARS��rating of 3.3 stars out of 5 stars.

10 Best Prefered Stocks To Invest In Right Now: Mint Corp (MIT)

The Mint Corporation is a vertically integrated prepaid card and payroll services provider with its own ATM network, payment processing platform and branded card product, including microcredit, mobile top up and money remittance services delivered seamlessly to workers globally. The Company operates through Mint Middle East LLC (MME), Mint Capital LLC (MCO), Mint Global Processing LLC (MGP) and Mint Electronic Payment Services LLC (MEPS). MME is a payroll card services provider facilitating an automated and secure payroll system to employers in the United Arab Emirates (UAE). MGP is an integrated third party processing platform and operates as a third party transaction processor to be based in the UAE. MCO manages the microfinance product in collaboration with Mawarid Finance PJSC. MEPS was formed to operate the business assets acquired from ePAY, a division of Global Business Systems for Multimedia. Advisors' Opinion:

• [By Rahul Chattaraj]

  Ford Motor (F) announced on Wednesday that it would start working with two U.S. universities to initiate research for driverless cars. The carmaker has teamed up with Stanford University and the Massachusetts Institute of Technology (MIT) to work out ways to overcome ��echnical challenges��surrounding this segment.

Hot Companies To Watch In Right Now: Mast Therapeutics Inc (MSTX)

Mast Therapeutics, Inc., formerly ADVENTRX Pharmaceuticals, Inc., incorporated in December 1995, is a development-stage company biopharmaceutical company focused on developing product candidates. The Company's product candidate is ANX-188, a rheologic, antithrombotic and cytoprotective agent that improves microvascular blood flow and has application in treating a range of diseases and conditions, such as complications arising from sickle cell disease. As of December 31, 2011, the Company also is developing ANX-514, a detergent-free formulation of the chemotherapy drug docetaxel. The Company offers ANX-188 (purified poloxamer 188), ANX-514 (docetaxel for injectable emulsion) and Exelbine (vinorelbine injectable emulsion). In April 2011, the Company acquired SynthRx, Inc. In February 2014, Mast Therapeutics Inc completed its acquisition of Aires Pharmaceuticals, Inc. Aires became a wholly-owned subsidiary of Mast Therapeutics.

ANX-188 (purified poloxamer 188)

ANX-188 is an aqueous solution of a purified form of poloxamer 188. Poloxamer 188 (P1880, is a nonionic, block copolymer that has been found to improve microvascular blood flow by reducing viscosity, particularly under low shear conditions, and by reducing adhesive frictional forces. The Company�� purified form of P188 (purified P188), which is the active ingredient in ANX-188, was designed to eliminate certain low molecular weight substances present in P188 (non-purified), which is primarily responsible for the moderate to moderately severe elevations in serum creatinine levels (acute renal dysfunction) observed in prior clinical studies of P188 (non-purified). Purified P188 has been evaluated in multiple clinical studies by a prior sponsor, including a 255-patient, phase III study.

ANX-514 (docetaxel for injectable emulsion)

ANX-514 is a detergent-free emulsion formulation of docetaxel, an intravenously-injected chemotherapy drug commonly used to treat solid tumors. Taxotere, a branded form! ulation of docetaxel, is approved to treat breast, non-small cell lung, prostate, gastric, and head and neck cancers. ANX-514 was designed to have clinically comparable release of docetaxel relative to Taxotere while eliminating the presence of polysorbate 80 and ethanol, both of which are used to solubilize docetaxel in the Taxotere formulation. The ANX-514 formulation solubilizes docetaxel using oil droplets consists of a combination of non-toxic excipients. Docetaxel is contained within these oil droplets and can be administered intravenously without using detergents as pharmaceutical vehicles. Once in central circulation, the emulsion is metabolized rapidly, leaving chemically-identical active ingredient to exert its cytotoxic effect. ANX-514 may reduce the incidence and severity of hypersensitivity reactions and delay the onset of fluid retention.

Exelbine (vinorelbine injectable emulsion)

Exelbine is an emulsion formulation of the chemotherapy drug vinorelbine. Navelbine, a branded formulation of vinorelbine, is approved in the United States to treat advanced non-small cell lung cancer as a single agent or in combination with cisplatin, and approved in the European Union to treat non-small cell lung cancer and advanced or metastatic breast cancer.

In August 2011, the Company received a complete response letter from the Food and Drug Administration (FDA) stating that it could not approve the Exelbine Non Disclosure Agreement (NDA) in its present form and that the bioequivalence study would need to be repeated because the authenticity of the drug products used in the bioequivalence trial could not be verified in accordance with FDA standards. However, the Company elected to discontinue independent development of Exelbine and as of December 31, 2011, the Company was seeking a partner or outside investor for the program to complete the necessary bioequivalence study.

The Company competes with GlaxoSmithKline, Provenge and Pfizer.

Advisors' Opinion:

• [By John Udovich]

  The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns�plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many�� planned biotech IPOs that have recently been announced publicly:

• [By Roberto Pedone]

   

  Mast Therapeutics (MSTX), a biopharmaceutical company, focuses on developing therapies for serious or life-threatening diseases. This stock closed up 2.1% 65 cents per share in Thursday's trading session.

   

  Thursday's Range: $0.63-$0.67
  
  52-Week Range: $0.40-$1.10
  
  Thursday's Volume: 1.11 million
  
  Three-Month Average Volume: 1.88 million

   

  From a technical perspective, MSTX spiked modestly higher here right above its 50-day moving average of 61 cents per share with decent upside volume. This stock has been trending sideways and consolidating for the last month, with shares moving between 60 cents on the downside and 72 cents on the upside. Shares of MSTX are now starting to push higher and into range of triggering a big breakout trade above the upper-end of its recent sideways trading chart pattern. That trade will hit if MSTX manages to clear some near-term overhead resistance levels at 68 to 72 cents per share with high volume.

   

  Traders should now look for long-biased trades in MSTX as long as it's trending above some key near-term support at 60 cents per share and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.88 million shares. If that breakout materializes soon, then MSTX will set up to re-test or possibly take out its next major overhead resistance levels at 80 to 85 cents per share, or even 93 cents per share.

   

Hot Companies To Watch In Right Now: Ressources Minieres Radisson Inc (RDS)

Ressources Minieres Radisson Inc., formerly Radisson Mining Resources Inc., is in the process of exploring mining properties. The Company has portfolio of four properties, covering a total area of 2,946 hectares. Three of these properties are located in Quebec and one in Ontario. The Company owns a 100% interest in O��rien 576-hectare property. The Company also owns 100% interest in Kewagama 111.7-hectare property. The Company�� O��rien/Kewagama project is located in the Cadillac-Malartic area, within the Abitibi gold belt. It consists of 36 claims covering an area of 729 hectares. The O��rien/Kewagama project lies approximately five kilometer west of Agnico-Eagle�� Lapa gold mine, also centred on the Cadillac Break, and approximately four kilometer southwest of Agnico-Eagle�� Laronde mine, over 3,000 meters (10,000 feet) in depth. Advisors' Opinion:

• [By Jim Jubak]

  The latest news to make me wonder if the stock has hit a bottom came out in an interview that the CEO of Royal Dutch Shell (RDS) gave to the Financial Times yesterday, April 1. CEO Ben Van Beurden said that in an effort to make a profit in the company�� North American operations, the company had launched ��roject Mosaic��to cut costs in its North American shale operations, by sourcing more equipment from cheaper Asian suppliers.

Hot Companies To Watch In Right Now: Pershing Gold Corp (PGLC)

Pershing Gold Corporation, incorporated on August 2, 2007, is a gold and precious metals exploration company. The Company is pursuing exploration and development opportunities primarily in Nevada. It is focused on exploration at its Relief Canyon properties in Pershing County in northwestern Nevada. None of the Company�� properties contain proven and probable reserves, and all of its activities on all of its properties are exploratory in nature. The Company seeks properties with known mineralization that are in an advanced stage of exploration and have previously undergone some drilling but are under-explored. It is focused on exploration of the Relief Canyon properties, recommissioning the Relief Canyon gold processing facility and, if economically feasible, commencing mining at the Relief Canyon Mine.

Relief Canyon Mine Property

The Company�� Relief Canyon properties totals approximately 25,000 acres and consists of approximately 940 owned unpatented mining claims, 120 owned millsite claims, 170 leased unpatented mining claims, and leased and subleased private lands. The Company drilled 44 holes for approximately 28,500 feet in 2013. This drilling was on land adjacent to the current deposit and focused on extending and upgrading the existing deposit. In January 2013 the Company reported 32,541,000 tons of mineralized material at an average grade of 0.017 ounces of gold per ton and a cut-off grade of 0.0046 ounces of gold per ton.

Advisors' Opinion:

• [By ValueInvestor7]

  I listen to investing advice from self-made billionaire investors, and I try to ignore advice from everyone else. I suspect readers on this website will appreciate this, where thankfully the Focus is still Gurus. To this end, I bring you the instructive story of Pershing Gold Corp (PGLC) and Levon Resources (TSE: LVN) (LVNVF).

Hot Companies To Watch In Right Now: Duke Realty Corporation (DRE)

Duke Realty Corporation operates as a real estate investment trust (REIT) in the United States. It offers leasing, property and asset management, development, construction, build-to-suit, and other tenant-related services. As of December 31, 2006, Duke Realty owned approximately 721 industrial, office, and retail properties comprising 113.8 million rentable square feet, as well as owned 6,400 acres of unencumbered land for development. The company has elected to be taxed as REIT under the Internal Revenue Code. As a REIT, it would not be subject to federal income tax purposes, provided that it distributes at least 90% of its REIT taxable income to its shareholders. The company was founded in 1972 and is headquartered in Indianapolis, Indiana with regional offices in Alexandria, Virginia; Atlanta, Georgia; Cincinnati, Columbus, and Cleveland, Ohio; Chicago, Illinois; Dallas and Houston, Texas; Minneapolis, Minnesota; Nashville, Tennessee; Orlando, Florida; Phoenix, Arizona; Raleigh, North Carolina; St. Louis, Missouri; and Tampa and Weston, Florida.

Advisors' Opinion:

• [By Brad Thomas]

  Other REITs mentioned: (O), (NNN), (STAG), (DCT), (EGP), (PDM), (DRE), (LRY)

  Source: Chambers Street: More Liquidity Magic On The Way In REIT-Dom

  Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More...)

Hot Companies To Watch In Right Now: Elisa Oyj (ELI1V)

Elisa Oyj is a Finland-based Company engaged in the provision of Information and Communication Technology (ICT) services in Finland and Estonia. The Company operates within two business segments: Consumer Customers and Corporate Customers. The Consumer Customers segment provides consumers and households with telecommunications services, such as voice and data services. The Corporate Customers segment provides to the corporate and community customers voice and data services, ICT solutions and contact center services. All the services are provided under the Elisa and Saunalahti brands. The Company�� global alliance partners are Vodafone and Telenor. The Company operates through its subsidiaries, including Appelsiini Finland Oy, Arediv Oy, Ecosite Oy and Elisa Eesti As, among others. Advisors' Opinion:

• [By Adam Ewing]

  A sale would provide the shareholders with cash, while potentially strengthening DNA against larger rivals Elisa Oyj (ELI1V) and TeliaSonera AB. (TLSN) The IPO could be the biggest in Finland, home of Nokia Oyj (NOK1V) and ��ngry Birds��maker Rovio Entertainment Oy, since 2005.